Tag
GLP-1
GLP-1 medication costs, utilization trends, actuarial impact on health insurance pricing, and pharmacy benefit management strategies.
Life Insurance
Life Insurance Industry Trends 2026: From Record Sales to a Generational Crossroads
February 21, 2026LIMRA projects 2–6% premium growth, IUL/VUL dominate at 42% market share, 102M Americans underinsured, GLP-1 mortality impacts, AI-driven underwriting, and estate tax reform. Comprehensive actuarial analysis.
Read article →
Health Insurance
Healthcare Cost Trends 2026: What Actuaries Need to Know About the Forces Reshaping Medical Spending
February 21, 20268.5–9.5% medical cost trend consensus, GLP-1 drugs reshaping pharmacy spend, behavioral health surges, oncology costs, provider inflation, and what it means for actuarial pricing and reserving.
Read article →
Health Insurance
ACA Marketplace 2026: Subsidy Cliff, Enrollment Shock, and What Actuaries Need to Know
February 21, 2026Enhanced subsidies expired, enrollment dropped to ~23M, median premiums up 18%, Aetna exited. Deep actuarial analysis of risk pool dynamics, adverse selection, state subsidies, and GLP-1 cost pressures.
Read article →